Question for the board: From the PR today, it sounds like they are going to separate GNBT from the Nugenerex and create a new publicly traded stock. "The spin-out of NuGenerex Immuno-Oncology into a separate, publicly traded entity has been the focus of the Generex strategic development plan in cancer drug development," Mr. Moscato indicated. So how does this affect GNBT?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links